BPR1K871
Product Specifications
CAS Number
2443767-35-7
Target
FLT
Related Pathways
Angiogenesis, Tyrosine Kinase/Adaptors
Bioactivity
BPR1K871, a preclinical development candidate for anti-cancer therapy [1], is a potent, selective dual inhibitor targeting FLT3 and AURKA, with IC50 values of 19 nM and 22 nM, respectively.
Smiles
CN(C)CCCOc1ccc2c(NCCc3cnc(NC(=O)Nc4cccc(Cl)c4)s3)ncnc2c1
Molecular Formula
C25H28ClN7O2S
Molecular Weight
526.05
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb3157088 100 µg
Probable rRNA-processing protein EBP2 Antibody (Cy3)
Sign In for Pricing
View Details MBS2133328-01 0.1 mL
PE Linked Polyclonal Antibody to Mannose Receptor C Type 1 (MRC1)
Sign In for Pricing
View Details MBS2133328-02 0.2 mL
PE Linked Polyclonal Antibody to Mannose Receptor C Type 1 (MRC1)
Sign In for Pricing
View Details MBS2133328-03 0.5 mL
PE Linked Polyclonal Antibody to Mannose Receptor C Type 1 (MRC1)
Sign In for Pricing
View Details MBS2133328-04 1 mL
PE Linked Polyclonal Antibody to Mannose Receptor C Type 1 (MRC1)
Sign In for Pricing
View Details MBS2133328-05 5 mL
PE Linked Polyclonal Antibody to Mannose Receptor C Type 1 (MRC1)
Sign In for Pricing
View Details